NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jessica Gartrell, MD
St. Jude Children's Research Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
Kathryn Sutton, MDNot, yet, recruiting - Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
Jennifer Reicheck, MDRecruiting - Our Lady of the Lake Children'S Hospital
Baton Rouge, Louisiana, United States
Jeffrey Deyo, MDRecruiting - Dana Farber Cancer Institute
Boston, Massachusetts, United States
Natalie Collins, MDRecruiting - Washington University Medical Center
St Louis, Missouri, United States
Amy Armstrong, MDRecruiting - Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Brian Turpin, MDRecruiting - St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
Jessica Gartrell, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Mar 2024
- Primary completion
- 30 Jun 2034
- Completion
- 30 Jun 2037
- Last update posted
- 6 Jul 2026
- Registered enrollment
- 139
- Registry id
- NCT06239272
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.